These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9044517)

  • 1. Comparison of transdermal nitroglycerin and intracavernous injection of papaverine in the treatment of erectile dysfunction in patients with spinal cord lesions.
    Renganathan R; Suranjan B; Kurien T
    Spinal Cord; 1997 Feb; 35(2):99-103. PubMed ID: 9044517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcutaneous nitroglycerin in the treatment of erectile dysfunction in spinal cord injured.
    Sønksen J; Biering-Sørensen F
    Paraplegia; 1992 Aug; 30(8):554-7. PubMed ID: 1522996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intracavernous injection of papaverine hydrochloride for impotence in patients with spinal cord injury].
    Momose H; Natsume O; Yamamoto M; Suemori T; Yamada K
    Hinyokika Kiyo; 1987 Jul; 33(7):1065-9. PubMed ID: 3687629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intracavernous injections in the treatment of erectile dysfunction in spinal cord injured patients: experience with 36 patients].
    Lebib Ben Achour S; Laffont I; Boyer F; Boiteau F; Dizien O
    Ann Readapt Med Phys; 2001 Feb; 44(1):35-40. PubMed ID: 11587653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracavernous injection of vasoactive drugs, an alternative for treating impotence in spinal cord injury patients.
    Wyndaele JJ; de Meyer JM; de Sy WA; Claessens H
    Paraplegia; 1986 Oct; 24(5):271-5. PubMed ID: 3774363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracavernous Injections in Spinal Cord Injured Men With Erectile Dysfunction, a Systematic Review and Meta-Analysis.
    Chochina L; Naudet F; Chéhensse C; Manunta A; Damphousse M; Bonan I; Giuliano F
    Sex Med Rev; 2016 Jul; 4(3):257-269. PubMed ID: 27871959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracavernous papaverine for impotence in spinal cord injured patients.
    Kapoor VK; Chahal AS; Jyoti SP; Mundkur YJ; Kotwal SV; Mehta VK
    Paraplegia; 1993 Oct; 31(10):675-7. PubMed ID: 8259331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracavernous injection of prostaglandin E1 in spinal cord injured patients with erectile dysfunction. A preliminary report.
    Tang SF; Chu NK; Wong MK
    Paraplegia; 1995 Dec; 33(12):731-3. PubMed ID: 8927414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intracavernous self-injection for treatment of erectile dysfunction inpatients with spinal cord injuries].
    Sønksen JO; Hansen EF; Biering-Sørensen F; Colstrup H
    Ugeskr Laeger; 1990 Oct; 152(41):3006-9. PubMed ID: 2238171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Erectile dysfunction of male spinal cord injury patients].
    Schurch B; Kuhn W
    Schweiz Rundsch Med Prax; 1990 Sep; 79(38):1085-8. PubMed ID: 2218240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracavernous chlorpromazine versus phentolamine: a double-blind clinical comparative study.
    Shamloul R; El-Dakhly M; Ghanem H; Gadallah A; Mokhtar H
    J Sex Med; 2004 Nov; 1(3):310-3. PubMed ID: 16422961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective comparison of topical minoxidil to vacuum constriction device and intracorporeal papaverine injection in treatment of erectile dysfunction due to spinal cord injury.
    Chancellor MB; Rivas DA; Panzer DE; Freedman MK; Staas WE
    Urology; 1994 Mar; 43(3):365-9. PubMed ID: 8134992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracavernous injections for erectile dysfunction in patients with cardiovascular diseases and failure or contraindications for sildenafil citrate.
    Israilov S; Niv E; Livne PM; Shmueli J; Engelstein D; Segenreich E; Baniel J
    Int J Impot Res; 2002 Feb; 14(1):38-43. PubMed ID: 11896476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracavernous injection of papaverine as a diagnostic and therapeutic method in erectile failure.
    Virag R; Frydman D; Legman M; Virag H
    Angiology; 1984 Feb; 35(2):79-87. PubMed ID: 6696289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current role of intracavernous therapy in the treatment of erectile dysfunction].
    Asuar Aydillo S
    Arch Esp Urol; 2002 Jun; 55(5):475-82. PubMed ID: 12174413
    [No Abstract]   [Full Text] [Related]  

  • 16. What nonresponse to intracavernous injection really indicates: a determination by quantitative analysis.
    Elhanbly S; Schoor R; Elmogy M; Ross L; Hegazy A; Niederberger C
    J Urol; 2002 Jan; 167(1):192-6. PubMed ID: 11743303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short term use of intracavernous vasoactive drugs in the treatment of persistent psychogenic erectile dysfunction.
    Ghanem H; Sherif T; Adbel-Gawad T; Asaad T
    Int J Impot Res; 1998 Dec; 10(4):211-4. PubMed ID: 9884916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comments from Ronald Virag on intracavernous injection: 25 years later.
    Virag R
    J Sex Med; 2005 May; 2(3):289-90. PubMed ID: 16422859
    [No Abstract]   [Full Text] [Related]  

  • 19. Intracavernous pharmacotherapy for management of erectile dysfunction in spinal cord injury.
    Lloyd LK; Richards JS
    Paraplegia; 1989 Dec; 27(6):457-64. PubMed ID: 2608299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of intracavernosal vasoactive agents to overcome impotence due to spinal cord injury.
    Earle CM; Keogh EJ; Ker JK; Cherry DJ; Tulloch AG; Lord DJ
    Paraplegia; 1992 Apr; 30(4):273-6. PubMed ID: 1625897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.